It has been demonstrated that corilagin and polydatin inhibit NF-κB activation33–35, and in agreement with this finding, QC inhibited the phosphorylation of p65 and thus inactivated the NF-κB pathway in mice with DEN-induced liver cancer. Here, NFKB1 is linked to liver cancer.